India's first COVID-19 vaccine Covishield ready to roll-out in coming weeks: Adar Poonawalla
New Delhi: Adar Poonawalla, CEO, Serum Institute of India (SII) said on Sunday that the Covishield, India's first Covid-19 vaccine will roll out in the coming weeks. Poonawalla said SII risks on stockpiling the vaccine have paid off. His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield developed by AstraZeneca and...
New Delhi: Adar Poonawalla, CEO, Serum Institute of India (SII) said on Sunday that the Covishield, India's first Covid-19 vaccine will roll out in the coming weeks.
Poonawalla said SII risks on stockpiling the vaccine have paid off.
His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield developed by AstraZeneca and Oxford. Poonawalla added the vaccine is safe, effective and ready for rollout.
Read also: DCGI scraps impotency rumours as complete nonsense, says COVID-19 vaccines 110 percent safe
"Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks", he said in a tweet.
"Thank you Hon. Sri@narendramodiJi, Hon. Sri@drharshvardhanJi @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support", he added.
Read also: SII, Bharat Biotech get DCGI approval for Covishield, Covaxin respectively
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd